Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Genzyme Ireland Limited | Waterford, Ireland | Makes it, tests it, packages it and labels it | Problems found, fixed voluntarilyFeb 25, 2022 · 7 inspections |
| Regeneron Ireland Designated Activity Company | Limerick, Ireland | Makes the active ingredient and tests it | Problems found, fixed voluntarilyJun 13, 2025 · 2 inspections |
| Regeneron Pharmaceuticals, Inc. | Rensselaer, NY, United States | Makes the active ingredient and tests it | Problems found, fixed voluntarilyMar 22, 2024 · 10 inspections |
| Sanofi Winthrop Industrie | Vitry sur-Seine, France | Makes the active ingredient and tests it | Problems found, fixed voluntarilyOct 4, 2024 · 6 inspections |
| Sanofi-Aventis Deutschland GmbH | Frankfurt am Main, Germany | Makes it, tests it, packages it and labels it | Problems found, fixed voluntarilyMar 25, 2022 · 10 inspections, 1 with FDA action |
Product details
- Generic drug
- Alirocumab: every company that makes it
- Form
- injection, solution, subcutaneous
- Strength
- 150 mg per 1 mL
- Approval
- BLA BLA125559
- On the market since
- Jul 24, 2015
- Package NDCs
0024-5902-000024-5902-010024-5902-02- Official label
- DailyMed (National Library of Medicine), updated Jul 7, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?